Form 4: Ventas Inc. CEO Debra Cafaro Executes Option Exercises and Stock Sales Under 10b5-1 Plan
SEC Form 4
Debra Cafaro, Chairman and CEO of Ventas Inc., executed stock option exercises and subsequent sales of common stock under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Debra A. Cafaro, Chairman and CEO of Ventas, Inc., executed transactions involving Ventas common stock.
- On October 29, 2024, Cafaro exercised options to purchase 121,248 shares at a price of $65.94 per share and sold the same number of shares at a weighted average price of $66.1677.
- On October 30, 2024, Cafaro exercised options to purchase 34,085 shares at a price of $65.94 per share and sold the same number of shares at a weighted average price of $66.6669.
- The transactions were conducted under a Rule 10b5-1 trading plan established on March 28, 2024.
- Following these transactions, Cafaro directly owns 986,717 shares of Ventas common stock and holds options to purchase 1,186,347 shares.
Sentiment
Score: 6
Explanation: Neutral sentiment as the document simply reports transactions under a pre-existing plan. No indication of positive or negative outlook.
Positives
- The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, which can mitigate concerns about insider trading.
Industry Context
Executive stock transactions are common and closely monitored in the REIT industry. The use of a 10b5-1 plan is a standard practice to allow insiders to sell shares without raising concerns about trading on non-public information.
Comparison to Industry Standards
- Many REIT executives use 10b5-1 trading plans to manage their stock holdings.
- The size of these transactions is not unusual for a CEO of a company the size of Ventas.
- Comparing Cafaro's transactions to those of CEOs at similar REITs like Welltower (WELL) or Healthpeak Properties (PEAK) would provide further context.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the increased supply of shares in the market, but the effect is likely minimal given the volume and the pre-planned nature of the sales.
Key Dates
| Date | Description |
|---|---|
| 01/21/2015 | Date when stock options were granted. |
| 03/28/2024 | Date the Rule 10b5-1 trading plan was entered into by the Reporting Person. |
| 10/29/2024 | Date of first reported transaction: exercise of options and sale of 121,248 shares. |
| 10/30/2024 | Date of second reported transaction: exercise of options and sale of 34,085 shares. |
| 01/21/2025 | Expiration date of the stock options exercised. |
| 10/31/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.